Tebamide
Tebamide Brand names, Tebamide Analogs
Tebamide Brand Names Mixture
- Alphasel tablets (calcium phosphate [dibasic] + cobalt sulfate + D-alpha tocopheryl acetate + selenium sulfide)
- Previte (neomycin sulfate + selenium sulfide + streptomycin sulfate + vitamin A + vitamin D + vitamin E + vitamin K1)
Tebamide Chemical_Formula
C14H12N6O
Tebamide RX_link
No information avaliable
Tebamide fda sheet
Tebamide msds (material safety sheet)
Tebamide Synthesis Reference
No information avaliable
Tebamide Molecular Weight
280.285 g/mol
Tebamide Melting Point
No information avaliable
Tebamide H2O Solubility
No information avaliable
Tebamide State
Solid
Tebamide LogP
2.759
Tebamide Dosage Forms
Intravenous (loading dose of 12 to 24 micrograms/kg over 10 minutes followed by a continuous infusion of 0.05 to 0.2 micrograms/kg per minute, adjusted according to response)
Tebamide Indication
For short term treatment of acutely decompensated severe chronic heart failure (CHF).
Tebamide Pharmacology
Levosimendan is a new Ca2+-sensitizing inotropic agent. Ca2+ sensitizers represent a new class of inotropic agents, which overcome the disadvantages associated with currently available inotropic agents in as they are not associated with an increased risk of arrhythmias, cell injury and death due to Ca2+ overload in myocardial cells; they do not increase the activation energy; and they have the potential to reverse contractile dysfunction under pathophysiologic conditions, such as acidosis or myocardial stunning. Levosimendan has not been approved for use in the U.S. or Canada.
Tebamide Absorption
The bioavailability of oral levosimendan is 85 ± 6% in healthy volunteers and 84 ± 4% in patients.
Tebamide side effects and Toxicity
No information avaliable
Tebamide Patient Information
No information avaliable
Tebamide Organisms Affected
Humans and other mammals
